The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis.

George A KanakisA ChrisoulidouA BargiotaZ A EfstathiadouL PapanastasiouA TheodoropoulouS K TigasD A VassiliadiS TsagarakisM Alevizaki

Published in: Clinical endocrinology (2016)

Discrepancy between GH and IGF-I results is encountered in a quarter of treated patients with acromegaly, especially when using ultrasensitive GH assays or in patients receiving SSAs, a fact that the clinician should take into consideration when making clinical decisions.

Keyphrases

growth hormone
newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
high throughput
quantum dots
cell proliferation
molecularly imprinted
solid phase extraction